Campbell Bradley L 4
4 · AMICUS THERAPEUTICS, INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Campbell Bradley L
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-01-02$9.31/sh−20,647$192,224→ 866,007 total - Tax Payment
Common Stock
2025-01-04$9.41/sh−7,368$69,333→ 1,083,693 total - Award
Stock Options (right to buy)
2025-01-03+482,908→ 482,908 totalExercise: $9.41Exp: 2035-01-03→ Common Stock (482,908 underlying) - Tax Payment
Common Stock
2025-01-03$9.41/sh−41,474$390,270→ 1,091,061 total - Award
Common Stock
2025-01-03+266,528→ 1,132,535 total
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2026 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.